To explore the mechanisms underlying the clinical associations between chemerin signaling and hepatocellular carcinoma, Lin et al. and Li et al. utilized mouse models in which chemerin expression was manipulated in several complementary manners [77,92]. This evidence concerns the gene RARRES2 and hepatocellular carcinoma.